BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ni J, Miao T, Su M, Khan NU, Ju X, Chen H, Liu F, Han L. PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases. Journal of Controlled Release 2021;329:934-47. [DOI: 10.1016/j.jconrel.2020.10.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Jia W, Liu R, Wang Y, Hu C, Yu W, Zhou Y, Wang L, Zhang M, Gao H, Gao X. Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.03.010] [Reference Citation Analysis]
2 Ju X, Miao T, Chen H, Ni J, Han L. Overcoming Mfsd2a-Mediated Low Transcytosis to Boost Nanoparticle Delivery to Brain for Chemotherapy of Brain Metastases. Adv Healthc Mater 2021;10:e2001997. [PMID: 33738958 DOI: 10.1002/adhm.202001997] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
3 Vasey CE, Cavanagh RJ, Taresco V, Moloney C, Smith S, Rahman R, Alexander C. Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations. Pharmaceutics 2021;13:208. [PMID: 33546301 DOI: 10.3390/pharmaceutics13020208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Chu Y, Luo Y, Su B, Li C, Guo Q, Zhang Y, Liu P, Chen H, Zhao Z, Zhou Z, Wang Y, Jiang C, Sun T. A Neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia-triggered differentiation therapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.05.027] [Reference Citation Analysis]
5 Ju X, Chen H, Miao T, Ni J, Han L. Prodrug Delivery Using Dual-Targeting Nanoparticles To Treat Breast Cancer Brain Metastases. Mol Pharm 2021;18:2694-702. [PMID: 34109794 DOI: 10.1021/acs.molpharmaceut.1c00224] [Reference Citation Analysis]
6 Singh M, Dahal A, Brastianos PK. Preclinical Solid Tumor Models to Study Novel Therapeutics in Brain Metastases. Curr Protoc 2021;1:e284. [PMID: 34762346 DOI: 10.1002/cpz1.284] [Reference Citation Analysis]
7 Han L. Brain metastases: Nanomedicine-boosted diagnosis and treatment. Medicine in Drug Discovery 2022;13:100111. [DOI: 10.1016/j.medidd.2021.100111] [Reference Citation Analysis]
8 Carney CP, Pandey N, Kapur A, Woodworth GF, Winkles JA, Kim AJ. Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases. Drug Deliv Transl Res 2021;11:2344-70. [PMID: 34716900 DOI: 10.1007/s13346-021-01039-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang Y, Guo P, Ma Z, Lu P, Kebebe D, Liu Z. Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review. J Nanobiotechnology 2021;19:255. [PMID: 34425832 DOI: 10.1186/s12951-021-01002-3] [Reference Citation Analysis]
10 Chen H, Zhou M, Zeng Y, Miao T, Luo H, Tong Y, Zhao M, Mu R, Gu J, Yang S, Han L. Biomimetic Lipopolysaccharide-Free Bacterial Outer Membrane-Functionalized Nanoparticles for Brain-Targeted Drug Delivery. Adv Sci (Weinh) 2022;9:e2105854. [PMID: 35355446 DOI: 10.1002/advs.202105854] [Reference Citation Analysis]
11 Liu R, Luo C, Pang Z, Zhang J, Ruan S, Wu M, Wang L, Sun T, Li N, Han L, Shi J, Huang Y, Guo W, Peng S, Zhou W, Gao H. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.05.032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cimini A, Ricci M, Russo F, Egidi M, Calabria F, Bagnato A, Schillaci O, Chiaravalloti A. Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview. Pharmaceuticals (Basel) 2021;14:872. [PMID: 34577572 DOI: 10.3390/ph14090872] [Reference Citation Analysis]
13 Han L. Modulation of the Blood-Brain Barrier for Drug Delivery to Brain. Pharmaceutics 2021;13:2024. [PMID: 34959306 DOI: 10.3390/pharmaceutics13122024] [Reference Citation Analysis]
14 Sadanandan N, Shear A, Brooks B, Saft M, Cabantan DAG, Kingsbury C, Zhang H, Anthony S, Wang ZJ, Salazar FE, Lezama Toledo AR, Rivera Monroy G, Vega Gonzales-Portillo J, Moscatello A, Lee JY, Borlongan CV. Treating Metastatic Brain Cancers With Stem Cells. Front Mol Neurosci 2021;14:749716. [PMID: 34899179 DOI: 10.3389/fnmol.2021.749716] [Reference Citation Analysis]
15 Wang Z, Sun C, Wu H, Xie J, Zhang T, Li Y, Xu X, Wang P, Wang C. Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer. Mater Today Bio 2022;13:100189. [PMID: 34977528 DOI: 10.1016/j.mtbio.2021.100189] [Reference Citation Analysis]